The Evidence News & Events Resource Center
Sight Sciences, based in Menlo Park, CA, is a leading medical technology company that specializes in the development of innovative surgical systems for the treatment of glaucoma. Their flagship product, the OMNI Surgical System, is the first and only device indicated for canaloplasty followed by trabeculotomy, offering a comprehensive solution for patients with primary open-angle glaucoma. With its intelligent design and advanced features, the OMNI Surgical System allows surgeons to target three points of resistance, delivering sustained long-term intraocular pressure reduction and providing patients with improved outcomes. With the launch of the Ergo-Series, Sight Sciences has further enhanced the OMNI Surgical System, introducing new cannula tip design, improved handle ergonomics, and simplified viscoelastic preparation. These key features enable surgeons to perform implant-free procedures in both standalone minimally invasive glaucoma surgery (MIGS) and combination cataract surgeries, offering a versatile and efficient solution for eye care professionals. Sight Sciences continues to be at the forefront of innovation in the field of ophthalmology, providing cutting-edge technologies that revolutionize the treatment of glaucoma and improve the quality of life for patients worldwide.Generated from the website